"The
Report House Dust Mite Allergy - Pipeline Review, H2 2016 provides
information on pricing, market analysis, shares, forecast, and
company profiles for key industry participants. -
MarketResearchReports.biz"
Global
Markets Directs, House
Dust Mite Allergy
- Pipeline Review, H2 2016, provides an overview of the House Dust
Mite Allergy pipeline landscape.
The
report provides comprehensive information on the therapeutics under
development for House Dust Mite Allergy, complete with analysis by
stage of development, drug target, mechanism of action (MoA), route
of administration (RoA) and molecule type. The report also covers the
descriptive pharmacological action of the therapeutics, its complete
research and development history and latest news and press releases.
Additionally, the report provides an overview of key players involved
in therapeutic development for House Dust Mite Allergy and features
dormant and discontinued projects.
Global
Markets Directs report features investigational drugs from across
globe covering over 20 therapy areas and nearly 3,000 indications.
The report is built using data and information sourced from Global
Markets Directs proprietary databases, company/university websites,
clinical trial registries, conferences, SEC filings, investor
presentations and featured press releases from company/university
sites and industry-specific third party sources. Drug profiles
featured in the report undergoes periodic review following a
stringent set of processes to ensure that all the profiles are
updated with the latest set of information. Additionally, various
dynamic tracking processes ensure that the most recent developments
are captured on a real time basis.
The
report helps in identifying and tracking emerging players in the
market and their portfolios, enhances decision making capabilities
and helps to create effective counter strategies to gain competitive
advantage.
Download
Sample copy of this Report at:
http://www.marketresearchreports.biz/sample/sample/794412
Scope
- The report provides a
snapshot of the global therapeutic landscape of House Dust Mite
Allergy
- The report reviews pipeline
therapeutics for House Dust Mite Allergy by companies and
universities/research institutes based on information derived from
company and industry-specific sources
- The report covers pipeline
products based on various stages of development ranging from
pre-registration till discovery and undisclosed stages
- The report features
descriptive drug profiles for the pipeline products which includes,
product description, descriptive MoA, R&D brief, licensing and
collaboration details & other developmental activities
- The report reviews key
players involved House Dust Mite Allergy therapeutics and enlists all
their major and minor projects
- The report assesses House
Dust Mite Allergy therapeutics based on drug target, mechanism of
action (MoA), route of administration (RoA) and molecule type
- The report summarizes all the
dormant and discontinued pipeline projects
- The report reviews latest
news related to pipeline therapeutics for House Dust Mite Allergy
Reasons to buy
- Gain strategically
significant competitor information, analysis, and insights to
formulate effective R&D strategies
- Identify emerging players
with potentially strong product portfolio and create effective
counter-strategies to gain competitive advantage
- Identify and understand
important and diverse types of therapeutics under development for
House Dust Mite Allergy
- Identify potential new
clients or partners in the target demographic
- Develop strategic initiatives
by understanding the focus areas of leading companies
- Plan mergers and acquisitions
effectively by identifying key players and its most promising
pipeline therapeutics
- Devise corrective measures
for pipeline projects by understanding House Dust Mite Allergy
pipeline depth and focus of Indication therapeutics
- Develop and design
in-licensing and out-licensing strategies by identifying prospective
partners with the most attractive projects to enhance and expand
business potential and scope
- Modify the therapeutic
portfolio by identifying discontinued projects and understanding the
factors that drove them from pipeline
Table
of Contents
Table of Contents 2
List of Tables 4
List of Figures 4
Introduction 5
Global Markets Direct Report
Coverage 5
House Dust Mite Allergy
Overview 6
Therapeutics Development 7
Pipeline Products for House
Dust Mite Allergy - Overview 7
House Dust Mite Allergy -
Therapeutics under Development by Companies 8
House Dust Mite Allergy -
Pipeline Products Glance 9
Late Stage Products 9
Clinical Stage Products 10
Early Stage Products 11
House Dust Mite Allergy -
Products under Development by Companies 12
House Dust Mite Allergy -
Companies Involved in Therapeutics Development 13
ALK-Abello A/S 13
Anergis SA 14
Biomay AG 15
Circassia Pharmaceuticals Plc
16
HAL Allergy BV 17
Stallergenes SAS 18
House Dust Mite Allergy -
Therapeutics Assessment 19
Assessment by Monotherapy
Products 19
Assessment by Combination
Products 20
Assessment by Target 21
Assessment by Route of
Administration 22
Assessment by Molecule Type 24
Drug Profiles 26
AllerDM - Drug Profile 26
Product Description 26
Mechanism Of Action 26
R&D Progress 26
Allergen for House Dust Mites
Induced Persistant Allergic Rhinitis and Rhinoconjunctivitis - Drug
Profile 27
Product Description 27
Mechanism Of Action 27
R&D Progress 27
BM-35 - Drug Profile 28
Product Description 28
Mechanism Of Action 28
R&D Progress 28
Follow
us on LinkedIn:
https://www.linkedin.com/company/marketresearchreports-biz
About
us
MarketResearchReports.biz
is the most comprehensive collection of market research reports.
MarketResearchReports.Biz services are specially designed to save
time and money for our clients. We are a one stop solution for all
your research needs, our main offerings are syndicated research
reports, custom research, subscription access and consulting
services. We serve all sizes and types of companies spanning across
various industries.
Contact
Mr.
Nachiket
State
Tower
90
Sate Street, Suite 700
Albany,
NY 12207
Tel:
+1-518-621-2074
No comments:
Post a Comment